argenx
The Director, Market Access, UK at argenx will lead pricing, reimbursement, market access, and policy activities across the UK and Ireland, shaping access strategies for innovative immunology therapies. This senior role involves influencing the UK leadership team, collaborating with global market access functions, and engaging with payers, regulators, and industry stakeholders.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
argenx didn’t post a salary, so this is our estimate from similar listings.
20% below the average for this role
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Director Market Access, UK & Ireland
BeOne Medicines
Market Access Director, Poland
Revolution Medicines
Associate Director, Market Access, Germany
Revolution Medicines
Market Access Director, Austria
Revolution Medicines
Senior Market Access Manager, Northern Europe
Illumina
Market Access Manager, BBU, UAE
AstraZeneca